Evidence map›Paper›PMID 41771148›Full record

ArticleJournal of the American Chemical Society2026

A Catalyst-Controlled Divergent Rearomatization of BN-Benzvalene.

Tomoya Ozaki, Yuping Dai, Bo Li, Karinne Miqueu, Shih-Yuan Liu

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Modular and Stereoselective Synthesis of Cyclobutane β-Amino Alcohols.Angewandte Chemie (International ed. in English) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomoya OzakiDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.
Yuping DaiUniversité de Pau et des Pays de l'Adour, E2S UPPA / CNRS, Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux IPREM UMR 5254, Hélioparc, 2 avenue P. Angot, 64053 Pau cedex 09, France.
Bo LiDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.
Karinne MiqueuUniversité de Pau et des Pays de l'Adour, E2S UPPA / CNRS, Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux IPREM UMR 5254, Hélioparc, 2 avenue P. Angot, 64053 Pau cedex 09, France.ORCID 0000-0002-5960-1877
Shih-Yuan LiuDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.ORCID 0000-0003-3148-9147

Funding

Expanding the Chemical and Functional Space with Boron-Nitrogen HeterocyclesR35GM153328 · NIGMS · BOSTON COLLEGE · PI Shih-Yuan Liu · 2024 to 2026
$1.3M
Bruker D8 VENTURE DiffractometerS10OD030360 · OD · BOSTON COLLEGE · PI LI, BO · 2022 to 2022
$428k
NIGMS NIH HHS R35 GM153328NIH HHS S10 OD030360
6 · The paper itself

Abstract

Carbon-based benzvalene undergoes diverse rearrangements upon exposure to external stimuli. In this report, we investigate the thermal and metal-catalyzed rearomatization pathways of BN-benzvalene, a boron-nitrogen-containing valence isomer of benzene. Depending on the choice of metal catalyst, these transformations selectively yield either C5- or C3-functionalized 1,2-azaborines. The C5-isomer formation serves as a proof of concept for a new molecular photoswitch system, while the C3-isomer formation represents the functional group transposition on the 1,2-azaborine scaffold. Mechanistic investigations, such as deuterium labeling studies and DFT calculations, suggest distinct operative pathways for the generation of each isomer.

Identifiers

PMID41771148
PMCPMC13293129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.